S&P 500
(0.02%) 5 422.12 points
Dow Jones
(-0.58%) 38 489 points
Nasdaq
(0.31%) 17 662 points
Oil
(-0.24%) $78.31
Gas
(-3.19%) $2.95
Gold
(-1.39%) $2 322.10
Silver
(-4.12%) $29.02
Platinum
(-2.09%) $950.70
USD/EUR
(0.54%) $0.930
USD/NOK
(0.84%) $10.66
USD/GBP
(0.29%) $0.784
USD/RUB
(-0.42%) $88.62

Realtime updates for Vir Biotechnology Inc [VIR]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated13 Jun 2024 @ 11:48

-2.96% $ 10.17

Live Chart Being Loaded With Signals

Commentary (13 Jun 2024 @ 11:48):
Our systems believe the stock currently is undervalued by 12.61% compare to its pairs and should correct upwards.
Profile picture for Vir Biotechnology Inc

Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; and VIR-1111 for the prevention of human immunodeficiency virus...

Stats
Today's Volume 247 418
Average Volume 993 409
Market Cap 1.38B
EPS $-0.480 ( Q1 | 2024-05-03 )
Next earnings date ( $-0.930 ) 2024-08-01
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -2.54
(Sector) 42.63
(Industry) 24.32
ATR14 $0.0130 (0.13%)
AADI -1.18%
ABCL -2.63%
ABCM 0.04%
ABEO 1.34%
ABIO 0.30%
ABOS -1.67%
ABSI -7.66%
ABUS -2.31%
ABVX -1.55%
ACAD -1.04%
ACER -17.95%
ACET 2.50%
ACGN 1.29%
ACHL -0.37%
ACHV -3.35%
ACIU 2.16%
ACLX 3.81%
ACRV 1.19%
ACST -0.15%
ACXP -3.21%
ADAG -3.41%
ADAP -1.13%
ADGI 0.87%
ADIL -1.55%
ADMA -0.65%
ADPT -1.99%
ADTX -3.85%
ADVM -2.54%
ADXN -3.04%
AEON -1.91%
AEZS 1.65%
AFMD 2.48%
AGEN -3.69%
AGIO -0.65%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -34.07%
AKBA -3.88%
AKRO -0.29%
AKTX -5.35%
AKUS 0.00%
ALBO 0.00%
ALDX 1.16%
ALEC 0.85%
ALGS 1.23%
ALKS -0.76%
ALLK -3.91%
ALLO -0.19%
ALLR -9.82%
ALNA 3.16%
ALNY 0.11%
ALPN 0.00%
ALPX 0.00%
ALRN -1.54%
ALT 1.25%
ALVR -0.29%
ALXN 0.00%
ALXO 0.59%
ALZN 2.04%
AMRN -1.44%
AMTI -3.13%
ANAB -0.83%
ANEB 5.09%
ANGN 0.00%
ANIX 1.32%
ANL -0.42%
ANNX 1.99%
ANPC -3.15%
APGE -3.36%
APGN 8.48%
APGNW 30.65%
APLM -4.48%
APLS -0.69%
APLT 0.66%
APM 0.85%
APOP 0.38%
APRE -3.14%
APTO 2.94%
APTX 3.17%
APVO -3.55%
ARAV -13.39%
ARCT 4.96%
ARDS 0.00%
ARDX -2.47%
ARGX 1.05%
ARNA 0.00%
ARPO -0.90%
ARQT 8.46%
ARTL 4.51%
ARTLW -1.43%
ARVN -1.40%
ARWR -0.58%
ASLN -0.51%
ASMB 0.79%
ASND -0.09%
ATAI 2.27%
ATHA -0.38%
ATHE -1.82%
ATHX -33.50%
ATNF 5.84%
ATOS -3.52%
ATRA -3.48%
ATXI 3.89%
ATXS -3.02%
AUPH 0.00%
AURA -0.83%
AUTL 0.46%
AVBP -0.11%
AVEO 0.00%
AVIR -1.06%
AVRO 0.00%
AVTE 2.48%
AVTX -2.05%
AVXL -0.13%
AXLA 0.00%
AXSM -1.26%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 1.26%
BCAB -3.48%
BCDA -0.14%
BCDAW 0.00%
BCEL 0.11%
BCLI -1.34%
BCRX -1.67%
BCTX 1.53%
BCTXW 0.00%
BCYC -0.90%
BDRX -1.99%
BDTX -0.64%
BEAM -1.04%
BFRA -2.91%
BGNE -2.26%
BIOR -0.23%
BIVI -1.87%
BLCM -6.68%
BLI -5.88%
BLPH 9.68%
BLRX 1.62%
BLTE -0.49%
BLU 0.03%
BLUE 2.66%
BMEA 23.11%
BMRN -0.96%
BNOX 9.19%
BNTC 1.34%
BNTX -1.94%
BOLD -10.68%
BOLT 0.29%
BPMC 0.98%
BPTH -1.23%
BPTS -13.47%
BRNS -1.06%
BRTX 28.42%
BTAI -2.05%
BTTX -12.22%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 5.93%
CABA -0.82%
CADL 0.40%
CALA -37.50%
CALC -0.99%
CALT -0.28%
CAPR 3.36%
CARA -33.81%
CARM 0.85%
CASI -5.59%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS 2.57%
CCCC -1.41%
CCXI 0.00%
CDAK 0.00%
CDIO 0.10%
CDIOW 3.62%
CDMO -8.15%
CDMOP 0.04%
CDT -7.44%
CDTTW 25.64%
CDTX -1.18%
CDXC 5.61%
CDXS -3.93%
CELC 1.03%
CELU -0.77%
CELUW -19.35%
CERC -1.68%
CERE 1.24%
CERO -36.04%
CEROW 13.07%
CFRX -27.95%
CGEM 1.61%
CGEN 0.74%
CGON -1.21%
CGTX -2.73%
CHMA -6.00%
CHRS -3.30%
CINC 0.00%
CING -0.88%
CINGW 79.28%
CKPT 2.45%
CLBS -16.75%
CLDX 0.53%
CLGN -1.38%
CLLS -3.41%
CLNN -3.14%
CLNNW -37.22%
CLRB 1.50%
CLSD 3.31%
CLSN -0.68%
CLVS 0.00%
CMMB -0.23%
CMND -2.79%
CMPI 0.00%
CMPX -3.75%
CMRA 0.40%
CMRAW 0.00%
CMRX -1.28%
CNCE 0.00%
CNSP 9.07%
CNST 0.00%
CNTA 3.30%
CNTB -7.18%
CNTX -1.00%
COCP 1.07%
COEPW -23.50%
COGT 0.44%
CORT -2.90%
COYA -3.46%
CPRX -1.33%
CRBP 5.28%
CRBU -3.04%
CRDF -0.17%
CRGX -1.52%
CRIS -0.45%
CRNX -0.84%
CRSP 3.17%
CRTX 2.63%
CRVO 10.76%
CRVS 0.97%
CSBR -4.05%
CTCX 7.00%
CTIC 0.06%
CTMX -3.01%
CTNM 2.64%
CTXR -2.91%
CUE 8.67%
CVAC -2.29%
CVKD -3.38%
CWBR 0.00%
CYAD -12.96%
CYCC -1.46%
CYCCP -1.79%
CYCN 3.18%
CYT -2.27%
CYTK -0.61%
CYTO -0.78%
DARE -3.63%
DAWN -2.00%
DBTX -0.81%
DBVT -1.86%
DFFN 10.28%
DICE 0.06%
DMAC -3.19%
DNLI 0.60%
DNTH 2.24%
DOMH -2.33%
DRMA 20.76%
DRMAW 0.00%
DRNA 0.00%
DRTS 1.72%
DRTSW 1.84%
DRUG -0.20%
DSGN -0.27%
DTIL -0.51%
DYAI 1.94%
EARS -1.77%
EDIT -2.98%
EDSA -4.92%
EFTR 2.95%
EFTRW -47.95%
EIGR 0.00%
ELAB -0.88%
ELDN 6.93%
ELEV -0.75%
ELOX 23.03%
ELTX -0.59%
ELVN -2.81%
ELYM -1.88%
ENGN -0.20%
ENGNW 4.41%
ENLV -2.86%
ENOB 1.79%
ENSC 1.27%
ENTA -0.75%
ENTO 7.91%
ENTX -5.94%
ENVB 1.21%
EPIX -5.58%
EPRX 1.10%
EPZM 0.00%
EQ -1.17%
EQRX -2.09%
EQRXW 0.00%
ERAS -1.35%
ERNA -1.79%
ERYP 1.30%
ESLA 5.32%
ESLAW -13.23%
ETNB -2.01%
ETON -0.83%
ETTX 0.00%
EVAX -2.79%
EVGN -0.85%
EVLO 50.00%
EWTX -0.89%
EXAI -3.17%
EXEL -0.16%
EYEG 0.46%
EYEN -1.63%
EYPT -2.36%
FATE -0.13%
FBIO -3.52%
FBIOP 0.00%
FBLG 3.92%
FBRX 1.63%
FDMT 0.66%
FENC -0.15%
FGEN -2.16%
FHTX -1.16%
FIXX 0.77%
FMTX 0.00%
FNCH 13.43%
FOLD 0.89%
FREQ 4.76%
FRLN 0.15%
FRTX -3.74%
FSTX 0.00%
FTRE -1.33%
FULC -0.97%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT -1.10%
GANX -5.45%
GBIO 2.27%
GBT 0.01%
GDTC 0.00%
GERN -3.83%
GHRS 2.31%
GLMD 5.85%
GLPG -1.07%
GLSI 2.79%
GLTO -3.62%
GLUE -2.40%
GLYC 2.86%
GMAB -1.49%
GMDA 0.00%
GMTX 0.00%
GNCA -85.71%
GNFT 0.65%
GNLX -2.28%
GNPX -4.06%
GNTA -4.55%
GOSS 0.19%
GOVX -6.04%
GOVXW 5.06%
GPCR 0.83%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS -0.19%
GRTX 2.93%
GTHX 1.74%
GUTS -0.16%
GXGXW 41.67%
GYRE 2.02%
HALO -0.69%
HARP 0.09%
HCWB 8.64%
HEPA -6.46%
HGEN -84.62%
HILS 5.66%
HLVX 0.34%
HOOK -0.22%
HOTH -1.86%
HOWL 5.54%
HRMY -0.03%
HRTX -1.09%
HSTO -38.33%
HUMA -0.96%
HUMAW -0.85%
IBRX 1.43%
ICCC -3.04%
ICPT 0.21%
ICU -5.71%
ICUCW 31.54%
ICVX -0.91%
IDRA -23.04%
IDYA 1.50%
IFRX -3.77%
IGMS -5.20%
IKNA 0.00%
IKT -1.90%
IMAB 0.00%
IMCR -2.83%
IMGN 0.02%
IMGO 0.00%
IMMP 6.64%
IMMX -3.27%
IMNM 0.44%
IMNN -2.50%
IMPL -27.27%
IMRA 15.96%
IMRN -1.75%
IMRX 6.94%
IMTX -0.38%
IMTXW 4.52%
IMUX -1.59%
IMV 0.00%
IMVT -0.08%
INAB 6.12%
INBX 0.12%
INCY 0.96%
INDP -3.04%
INFI -52.38%
INKT -0.09%
INM -4.39%
INMB -0.69%
INO -1.37%
INSM 1.64%
INTS -0.41%
INVA 0.60%
INZY -4.50%
IOBT -0.14%
IONS -1.04%
IOVA -3.05%
IPA 1.93%
IPHA -4.25%
IPSC -0.77%
IRON -0.49%
ISEE 0.38%
ITOS -1.64%
ITRM -1.26%
IVA -2.48%
IVVD 0.54%
JAGX -2.44%
JANX 1.64%
JAZZ 1.71%
JNCE 0.00%
JSPR 0.31%
JSPRW -22.19%
JUNS 0.00%
JUNSW 0%
KA 2.17%
KALV -1.38%
KDNY 0.22%
KMPH -0.34%
KNSA -1.48%
KNTE -0.38%
KOD 0.90%
KPRX -0.61%
KPTI 0.00%
KRBP -23.71%
KRON -16.39%
KROS 1.25%
KRRO -0.70%
KRTX 0.03%
KRYS 2.77%
KTRA -4.88%
KTTA -4.76%
KTTAW -27.22%
KURA -1.52%
KYMR 0.46%
KYTX 3.46%
KZIA -3.60%
KZR -1.25%
LABP 0.57%
LBPH 2.00%
LBPS 0.00%
LBPSW 14.81%
LEGN -3.93%
LENZ -1.39%
LEXX 4.35%
LEXXW 12.75%
LGND -0.12%
LGNDV 0.00%
LGVN 77.62%
LIAN 0.00%
LIFE 2.70%
LIPO 1.54%
LIXT -1.74%
LIXTW 0.14%
LJPC -0.32%
LMNL 0.12%
LOGC 0.28%
LPCN 0.63%
LPTX -1.15%
LQDA -0.90%
LRMR 0.00%
LSTA -0.23%
LTRN -2.58%
LUMO 1.39%
LVTX 4.80%
LXEO 2.25%
LXRX -3.93%
LYEL 1.37%
LYRA -2.42%
MACK 0.00%
MBIO -8.10%
MBRX 3.70%
MCRB -0.60%
MDGL 0.04%
MDNA -13.16%
MDWD -0.28%
MDXG -2.64%
MEIP -0.37%
MESO 0.92%
MGNX -3.78%
MGTA -7.74%
MGTX -1.92%
MGX 5.41%
MIRM -0.33%
MIRO 0.59%
MIST -1.42%
MITO 0.00%
MLEC -0.95%
MLECW 0.00%
MLND -5.36%
MLTX -0.44%
MLYS 0.63%
MNKD 1.71%
MNMD 1.67%
MNOV 1.48%
MNPR 4.44%
MOLN 0.86%
MOR -0.05%
MORF -1.36%
MREO 5.09%
MRKR -0.76%
MRNA -0.73%
MRNS -1.68%
MRSN -2.20%
MRTX -0.17%
MRUS 0.93%
MRVI -0.76%
MTCR -1.29%
MTEM -3.60%
MTP -18.50%
MURA -2.65%
MYMD 1.02%
NAMS -1.21%
NAMSW -3.36%
NAUT -4.61%
NBRV 0.71%
NBSE -1.56%
NBTX -3.27%
NCNA 0.66%
NERV 0.00%
NEXI -0.26%
NGM -1.28%
NGNE 5.43%
NKGN 5.38%
NKGNW 5.88%
NKTR -4.62%
NKTX -2.37%
NLSP -5.94%
NLSPW 61.29%
NMRA -1.70%
NMTR -42.97%
NOVN -24.84%
NRBO 0.82%
NRIX 1.27%
NRSN 2.80%
NRSNW 9.09%
NRXP 3.17%
NRXPW 57.60%
NRXS 5.54%
NTBL 1.02%
NTEC -12.45%
NTHI 0%
NTLA 1.39%
NTRBW -23.58%
NUVL -0.74%
NVAX -4.45%
NVCT -0.60%
NVIV -34.28%
NXTC 6.85%
NYMX -0.05%
OABI -3.86%
OABIW 6.52%
OBIO 2.77%
OBSV 0.00%
OCEA 0.35%
OCGN -0.98%
OCS -0.03%
OCUL -1.32%
OCUP -1.37%
ODT -4.27%
OKYO 2.66%
OLMA -2.25%
OMER 6.37%
OMGA -4.69%
ONCO -6.22%
ONCR -3.08%
ONCS 31.87%
ONCT 4.35%
ONCY 0.04%
ONTX -0.47%
ONVO -2.16%
OPNT 0.00%
OPT -0.79%
ORGS 10.36%
ORIC -4.62%
ORMP 0.64%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK 0.93%
OVID -1.72%
OYST 0.00%
PALI -0.63%
PASG 2.97%
PBLA 0.03%
PBM -2.57%
PBYI -2.08%
PCSA -1.88%
PCVX -0.20%
PDSB 4.78%
PEPG -1.75%
PGEN 0.90%
PHAR 0.12%
PHAS 0.00%
PHAT -1.70%
PHIO -1.20%
PHIOW 36.47%
PHVS -0.47%
PHXM -5.20%
PIRS -0.60%
PKBO 0.00%
PKBOW 0.00%
PLRX 2.04%
PLUR 0.18%
PMN 2.39%
PMVP -2.82%
PNT 0.16%
PPBT 5.86%
PRAX -3.26%
PRDS 0.93%
PRLD -0.74%
PROG -3.47%
PROK -4.68%
PRQR 1.11%
PRTA -1.72%
PRTC -0.13%
PRTG 2.14%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -2.97%
PSTX 0.36%
PTCT -2.36%
PTE -0.82%
PTGX 2.41%
PTIXW 0.00%
PULM 1.05%
PXMD 0.00%
PYPD -3.80%
PYXS -0.78%
QLGN -5.15%
QNCX -0.70%
QNRX -3.46%
QSI -1.32%
QSIAW -15.33%
QTTB -0.10%
QURE -0.76%
RAIN -1.63%
RANI 2.77%
RAPT -1.41%
RARE -2.22%
RCKT -0.18%
REGN 0.29%
RENB -3.50%
REPL 9.75%
RETA 0.02%
REUN -0.89%
REVB -1.78%
REVBU 3.46%
REVBW 16.55%
RGLS 5.50%
RGNX -1.67%
RIGL -3.23%
RLAY -1.66%
RLMD -0.58%
RLYB 1.82%
RNA 3.91%
RNAC -2.15%
RNAZ -2.81%
RNXT -5.13%
ROIV -0.25%
ROIVW 4.56%
RPHM -2.66%
RPRX -0.13%
RPTX 0.00%
RUBY 2.70%
RVLP -32.05%
RVMD -0.49%
RVMDW 30.88%
RVNC 1.98%
RVPH -1.95%
RVPHW 19.23%
RXDX 0.09%
RXRX -1.34%
RYTM 4.09%
RYZB 0.02%
RZLT -4.40%
SABS 2.08%
SABSW 14.54%
SAGE 3.69%
SANA 1.17%
SAVA 0.18%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI 8.27%
SCPH -0.13%
SCPS 0.00%
SEEL -3.06%
SEER -0.80%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO -6.10%
SGMT -0.19%
SGTX -2.56%
SIOX 22.63%
SLDB 6.18%
SLGL 1.13%
SLN -3.22%
SLNO -3.21%
SLRX -1.83%
SLS -0.69%
SMMT 0.48%
SNDX 1.33%
SNGX 10.14%
SNPX 1.16%
SONN -3.07%
SPPI -0.49%
SPRB 0.14%
SPRC 3.74%
SPRO -4.36%
SRNE -23.08%
SRPT 3.79%
SRRA 0.00%
SRRK 2.34%
SRZN 0.44%
STAB 0.00%
STOK -1.28%
STRO -1.54%
STSA 0.00%
STTK 2.71%
SURF -0.93%
SVRA -1.11%
SWTX 0.93%
SYBX 0.96%
SYRS 2.96%
TALS -0.73%
TARA -1.89%
TARS 0.79%
TBPH -0.35%
TCBP -2.68%
TCDA 0.00%
TCON -6.98%
TCRR 0.00%
TCRT -3.06%
TCRX 0.00%
TECH -1.39%
TENX -2.75%
TERN 2.17%
TFFP 3.63%
TGTX -0.09%
THRX 0.12%
TIL 0.77%
TLC 0.00%
TLSA -8.71%
TNGX 7.36%
TNXP 0.00%
TNYA -1.58%
TPST 0.32%
TRDA 2.20%
TRVI -1.05%
TRVN -1.79%
TSHA 4.21%
TSVT -3.57%
TTNP 6.44%
TVTX -3.13%
TYRA 1.73%
UBX -1.91%
UNCY 3.04%
URGN 41.27%
UTHR 1.28%
VACC 11.36%
VALN -12.14%
VAXX 0.00%
VBIV -5.72%
VBLT -8.77%
VCEL -1.98%
VCNX 2.14%
VCYT -2.03%
VERA -1.13%
VERU -1.40%
VERV 1.43%
VIGL -3.01%
VINC -3.81%
VIR -2.96%
VIRI -2.58%
VIRX -1.87%
VKTX 0.15%
VLON -13.04%
VNDA 12.08%
VOR -4.37%
VRCA 0.70%
VRDN 1.74%
VRNA 12.88%
VRPX -1.24%
VRTX 0.95%
VSTM 2.39%
VTGN -2.71%
VTVT 12.83%
VTYX -0.67%
VXRT -2.32%
VYGR 0.59%
VYNE -4.65%
VYNT 7.78%
WINT 4.00%
WVE 0.94%
XBIO 3.03%
XBIT -1.23%
XCUR -4.66%
XENE -0.60%
XERS -0.67%
XFOR -6.31%
XLO -0.98%
XLRN 0.00%
XNCR -0.86%
XOMA 6.04%
XOMAO -0.53%
XOMAP 0.04%
XRTX 7.54%
YMAB 0.00%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -1.15%
ZNTL -1.02%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2024-06-12 De Backer Marianne Sell 53 118 Common Stock
2024-06-12 De Backer Marianne Buy 53 118 Common Stock
2024-06-11 Ramasastry Saira Sell 4 000 Common Stock
2024-05-30 Sigal Charles Elliott Buy 8 000 Common Stock
2024-05-30 Sigal Charles Elliott Buy 16 000 Stock Option (Right to Buy)
INSIDER POWER
-12.76
Last 100 transactions
Buy: 6 543 698 | Sell: 8 941 068
Correlation (AI algo v.1.1b): Undervalued: 12.61% $11.45 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: -0.12 (neutral)
Short: 0.69 (moderate)
Signal:(45.533) Neutral

Vir Biotechnology Inc Correlation

10 Most Positive Correlations
TERN0.827
KMDA0.801
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Vir Biotechnology Inc Correlation - Currency/Commodity

The country flag 0.20
( neutral )
The country flag -0.10
( neutral )
The country flag 0.00
( neutral )
The country flag -0.05
( neutral )
The country flag 0.00
( neutral )
The country flag 0.23
( neutral )

Vir Biotechnology Inc Financials

Annual 2023
Revenue: $86.18M
Gross Profit: $63.96M (74.22 %)
EPS: $-4.59
FY 2023
Revenue: $86.18M
Gross Profit: $63.96M (74.22 %)
EPS: $-4.59
FY 2022
Revenue: $1.58B
Gross Profit: $1.43B (90.74 %)
EPS: $3.89
FY 2021
Revenue: $1.10B
Gross Profit: $1.03B (93.99 %)
EPS: $4.44

Financial Reports:

No articles found.

Vir Biotechnology Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Vir Biotechnology Inc

Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; and VIR-1111 for the prevention of human immunodeficiency virus. The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited and Brii Biosciences Offshore Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with The Rockefeller University and MedImmune, Inc.; collaboration with WuXi Biologics and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals SA. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. for the manufacture of SARS-COV-2 antibodies; and clinical collaboration with Gilead Sciences, Inc. for chronic hepatitis B virus. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 2.0528528690338 seconds
Number of API calls: 3
Number of DB calls: 9